BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Potměšil P. What combinations of agomelatine with other antidepressants could be successful during the treatment of major depressive disorder or anxiety disorders in clinical practice? Ther Adv Psychopharmacol 2019;9:2045125319855206. [PMID: 31312426 DOI: 10.1177/2045125319855206] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Poleszak E, Wośko S, Sławińska K, Wyska E, Szopa A, Świąder K, Wróbel A, Doboszewska U, Wlaź P, Wlaź A, Serefko A. Influence of the CB1 and CB2 cannabinoid receptor ligands on the activity of atypical antidepressant drugs in the behavioural tests in mice. Pharmacology Biochemistry and Behavior 2020;188:172833. [DOI: 10.1016/j.pbb.2019.172833] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Wang S, Xu Q, Qu K, Wang J, Zhou Z. CYP1A2 polymorphism may contribute to agomelatine-induced acute liver injury: Case report and review of the literature. Medicine (Baltimore) 2021;100:e27736. [PMID: 34766583 DOI: 10.1097/MD.0000000000027736] [Reference Citation Analysis]
3 Kaur M, Sanches M. Experimental Therapeutics in Treatment-Resistant Major Depressive Disorder. J Exp Pharmacol 2021;13:181-96. [PMID: 33658867 DOI: 10.2147/JEP.S259302] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Noseda ACD, Rodrigues LS, Targa ADS, Ilkiw JL, Fagotti J, Dos Santos PD, Cecon E, Markus RP, Solimena M, Jockers R, Lima MMS. MT2 melatonin receptors expressed in the olfactory bulb modulate depressive-like behavior and olfaction in the 6-OHDA model of Parkinson's disease. Eur J Pharmacol 2021;891:173722. [PMID: 33159932 DOI: 10.1016/j.ejphar.2020.173722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Lampela P, Tanskanen A, Lähteenvuo M, Tiihonen J, Taipale H. Switches and early discontinuations of antidepressant medication in young adults with depression. J Affect Disord 2021;295:1474-81. [PMID: 34565589 DOI: 10.1016/j.jad.2021.09.034] [Reference Citation Analysis]